AstraZeneca's Calquence has hit the mark in the phase 3 AMPLIFY trial in chronic lymphocytic leukaemia (CLL), a study that chief executive Pascal Soriot recently said could be a "blockbuster ...

You know the kid that always got in trouble for talking too much, or always asking a lot of questions? Yea, that was me. I grew up in Decatur, Georgia and earned my Bachelor of Arts degree from ...